OxTalks is Changing
During Michaelmas Term, OxTalks will be moving to a new platform (full details are available on the Staff Gateway).
For now, continue using the current page and event submission process (freeze period dates to be advised).
If you have any questions, please contact halo@digital.ox.ac.uk
From immune regulation to anti-tumor effects: A tale of cytotoxic regulatory T cells
In person
Achieving a graft-versus-leukemia (GVL) effect while suppressing graft versus host disease (GVHD) is the ultimate goal for allogeneic hematopoietic cell transplantation. Circulating CD8 regulatory T cells (Treg) that are capable of immunosuppression and cytolysis are rare. Therefore, we developed a protocol to generate human CD8 induced Tregs that are expansile and possess dual CD8 CTL cytotoxicity, consistent with their cell surface and intracellular expression patterns. When transduced with a chimeric antigen receptor, CD8 iTregs and cytotoxic T cells are equally cytolytic against their targets in vitro and in vivo, reflecting their dual function. Mechanism(s) underlying these properties will be discussed.
Date:
4 October 2024, 12:00
Venue:
Kennedy Institute of Rheumatology, Headington OX3 7FY
Venue Details:
Kennedy Lecture Theatre
Speaker:
Prof Bruce Blazar (University of Minnesota)
Organising department:
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS)
Organiser:
Doris Chan (Kennedy Institute of Rheumatology)
Organiser contact email address:
doris.chan@kennedy.ox.ac.uk
Host:
Michael Dustin (Kennedy Institute, University of Oxford)
Part of:
Kennedy Institute Seminars
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Doris Chan
